Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
St George's, University of London
Londres, Reino UnidoPublicacións en colaboración con investigadores/as de St George's, University of London (26)
2024
-
Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalemia or High Risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry
Journal of Cardiac Failure
-
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction – the ESC EORP Heart Failure III Registry
European Journal of Heart Failure
-
Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report
International Journal of Cardiology, Vol. 395
2023
-
A foundation model for generalizable disease detection from retinal images
Nature, Vol. 622, Núm. 7981, pp. 156-163
-
Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology
European Journal of Heart Failure, Vol. 25, Núm. 4, pp. 457-468
2022
-
Children living with HIV in Europe: do migrants have worse treatment outcomes?
HIV Medicine, Vol. 23, Núm. 2, pp. 186-196
-
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases
Heart Rhythm, Vol. 19, Núm. 7, pp. e1-e60
-
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases
Journal of Arrhythmia, Vol. 38, Núm. 4, pp. 491-553
-
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 24, Núm. 8, pp. 1307-1367
2021
-
Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: Observational study using prospectively collected registry data
BMJ, Vol. 375
-
EEG measures for clinical research in major vascular cognitive impairment: recommendations by an expert panel
Neurobiology of Aging, Vol. 103, pp. 78-97
2019
2018
-
Diagnostic yield of genetic testing in young athletes with t-wave inversion
Circulation, Vol. 138, Núm. 12, pp. 1184-1194
-
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
Indian Heart Journal, Vol. 70, Núm. 6, pp. 828-835
2016
-
Contemporary management of acute right ventricular failure: A statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology
European Journal of Heart Failure, Vol. 18, Núm. 3, pp. 226-241
-
Genome-wide associations for birth weight and correlations with adult disease
Nature, Vol. 538, Núm. 7624, pp. 248-252
2015
-
Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation?: The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation
Circulation: Cardiovascular Quality and Outcomes, Vol. 8, pp. S12-S20
2008
-
Ischemia-modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain
Heart and Vessels, Vol. 23, Núm. 3, pp. 174-180
2006
-
Effects of balloon occlusion during percutaneous coronary intervention on circulating Ischemia Modified Albumin and transmyocardial lactate extraction
Heart, Vol. 92, Núm. 12, pp. 1852-1853
-
Inflamación, aterosclerosis y riesgo cardiovascular: PAPP-A, Lp-PLA2 y cistatina C. ¿Nuevas aportaciones o información redundante?
Revista Espanola de Cardiologia, Vol. 59, Núm. 3, pp. 248-258